MetaCap

Cellyan Biotechnology Statistics

NASDAQ: HKPDHealthcareMedical DistributionUSD

0.1008-0.0029 (-2.80%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

Cellyan Biotechnology by the numbers

Cellyan Biotechnology has a market capitalization of $5.0 million based on 42.17M shares outstanding. With trailing EPS of $-0.07, Cellyan Biotechnology is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 60.7% below its 50-day average and 80.8% below its 200-day average.

Average daily trading volume is 3.77M shares, or about $380,195 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

HKPD valuation vs. peer median

HKPD compared with the median of 4 peer companies
MetricHKPDPeer medianDifference
Market cap$4.97M$29.63M-83%
Avg. volume3.77M2.82M+34%

Peer median across 4 companies: MEDS, YI, COSM, ACH.

Valuation

Price and trading

Previous close
0.1037
Open
0.098
Day range
0.095 – 0.1008
52-week range
0.095 – 1.72
Beta
—
Volume
580.48K

Dividends and events

Additional statistics

Market Cap
4.97M
Eps
-0.07
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
1.72
Week52 Low
0.10
Avg Volume
3.77M
Shares Outstanding
42.17M
Ma50
0.26
Ma200
0.53
Pct From52w High
-94.14%
Pct From52w Low
6.11%

Related